Search Results 151-160 of 16841 for Lou Gehrig's disease

  1. Incobotulinumtoxina (intraglandular route, intramuscular route) - Side effects & uses - Mayo Clinic

    Amyotrophic lateral sclerosis (Lou Gehrig's disease) or; Cornea or eye problems (eg, ulcers) or; Lambert-Eaton syndrome (nerve-muscle disorder) or; Motor ...

  2. Unleashing the body's ability to heal - Mayo Clinic News Network

    It manufactures cell products for investigating challenging diseases with no therapeutic options, such as Lou Gehrig's disease, or amyotrophic lateral sclerosis ...

  3. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR ( ...

  4. Mayo Clinic Neuropathologist Awarded International Professional Society’s Highest Honor

    ... disorders, such as Lewy body dementia, frontal lobe dementia and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. More recently, he ...

  5. A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS).

  6. Neurosciences Clinical Trials - Medical Professionals

    HEALEY ALS Platform Trial. Rochester, Minn ... ALS. Submandibular Gland ... Disease Progression of Parkinson's Disease and REM Sleep Behavior Disorder.

  7. Abobotulinumtoxina (intramuscular route) - Side effects & uses - Mayo Clinic

    Other Medical Problems · Amyotrophic lateral sclerosis (Lou Gehrig's disease) or · Dermatochalasis (a skin problem) or · Lambert-Eaton syndrome (nerve-muscle ...

  8. A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis - Mayo Clinic

    ... (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  9. Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS - Mayo Clinic

    ... (ALS), based on the time from the randomization date in Study MT-1186-A02 to at least a 12-point decrease in Revised ALS ... disease, and previous treatments or ...

  10. Neurology - Clinical trials

    Search for a disease or condition . Type 3 or ... syndrome (POTS). ... ALS we aim to eventually identify immune therapies that may provide benefit in ALS.